Autonomix Medical, Inc. Announces Closing of $11.2 Million in Gross Proceeds from Initial Public Offering
26. Januar 2024 16:05 ET
|
Autonomix Medical, Inc.
Shares to begin trading on NASDAQ on January 29, 2024 under the ticker symbol “AMIX” THE WOODLANDS, TX., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the...
Autonomix Medical, Inc. Successfully Completes Preclinical Safety Study to Support Program Advancement into First-in-Human Clinical Study to Treat Pancreatic Cancer Pain Through Transvascular Ablation
12. Januar 2024 10:00 ET
|
Autonomix Medical, Inc.
Patented two-fold technology in development to locate, ablate and confirm successful ablation of specific nerves for pain management and other uses All safety inputs met with no reported...
Autonomix Medical, Inc. Completes Formation of Engineering Development Team and Provides Project Update
11. Januar 2024 10:00 ET
|
Autonomix Medical, Inc.
Appointment of Marco Bedoya, a proven leader in medical device mechanical engineering, as Director of Product Development Engagements secured with preeminent firms to drive design and development...
Autonomix Medical, Inc. to Present at the Startup Investing Webinar
11. Januar 2024 09:00 ET
|
Autonomix Medical, Inc.
Live webcast roundtable discussion featuring Autonomix, Knightscope, and Infinity Fuel on Thursday, January 11th at 2:00 PM ET THE WOODLANDS, TX, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Autonomix...
Autonomix Medical, Inc. Provides Business Overview and Highlights Upcoming Milestones
04. Januar 2024 10:00 ET
|
Autonomix Medical, Inc.
Company developing potential breakthrough technology for the nervous system Patented two-fold technology that can potentially detect problematic neural signals and ablate nerves in one simple...
Autonomix Medical, Inc. to Participate in the Virtual Investor Fireside Chat
14. Dezember 2023 10:15 ET
|
Autonomix Medical, Inc.
Live moderated video webcast on Tuesday, December 19th at 3:00 PM ET THE WOODLANDS, TX, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device...
Autonomix Medical, Inc. to Present at the Virtual Investor Event Titled “A Breakthrough Medical Device for the Diagnosis and Treatment of Diseases of the Nervous System”
06. Dezember 2023 14:00 ET
|
Autonomix Medical, Inc.
Live moderated video webcast on Monday, December 11 at 2:00 PM ET THE WOODLANDS, TX, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device...
Autonomix Medical, Inc. Announces Appointment of Christopher C. Capelli, M.D. to Board of Directors
16. November 2023 10:00 ET
|
Autonomix Medical, Inc.
THE WOODLANDS, TX, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device company focused on advancing innovative technologies to revolutionize how...
Autonomix Medical, Inc. Launches Social Media Channels
08. November 2023 09:00 ET
|
Autonomix Medical, Inc.
Company developing innovative two-fold technology designed to both detect the neural signals relating to pain or disease and ablate them in one simple procedureOngoing progress toward launch of...